Aggrenox Buyers Slam Insurers' Bid To Opt Health Plans Out
Indirect buyers of the stroke prevention medicine Aggrenox on Wednesday slammed a request by six insurance companies to opt out hundreds of potential class members from a $54 million settlement agreement...To view the full article, register now.
Already a subscriber? Click here to view full article